# L_2022175EN.01004801.xml

| 30.6.2022 | EN | Official Journal of the European Union | L 175/48 |
| --- | --- | --- | --- |

30.6.2022

EN

Official Journal of the European Union

L 175/48

---

DECISION OF THE EEA JOINT COMMITTEE No 30/2022

of 4 February 2022

on the entry into force of Decision of the EEA Joint Committee No 371/2021 of 10 December 2021 [2022/1078]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use (1) and Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (2) were incorporated into the EEA Agreement by Decision of the EEA Joint Committee No 371/2021 of 10 December 2021 (3). |
| --- | --- |

(1)

Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018 amending Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency, Regulation (EC) No 1901/2006 on medicinal products for paediatric use and Directive 2001/83/EC on the Community code relating to medicinal products for human use (1) and Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC (2) were incorporated into the EEA Agreement by Decision of the EEA Joint Committee No 371/2021 of 10 December 2021 (3).

| (2) | Decision of the EEA Joint Committee No 371/2021 of 10 December 2021 should enter into force on the day following the last notification under Article 103(1) of the EEA Agreement in respect of that Decision, |
| --- | --- |

(2)

Decision of the EEA Joint Committee No 371/2021 of 10 December 2021 should enter into force on the day following the last notification under Article 103(1) of the EEA Agreement in respect of that Decision,

HAS ADOPTED THIS DECISION:

Article 1

Notwithstanding its Article 5, Decision of the EEA Joint Committee No 371/2021 of 10 December 2021 shall enter into force on the day following the last notification under Article 103(1) of the EEA Agreement in respect of that Decision.

Article 2

This Decision shall enter into force on 5 February 2022, or on the day following the last notification under Article 103(1) of the EEA Agreement (*), whichever is the later.

Article 3

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 4 February 2022.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

---

(1)  
  OJ L 4, 7.1.2019, p. 24.

1

(2)  
  OJ L 4, 7.1.2019, p. 43.

2

(3)  Not yet published in the Official Journal.

3

(*)  No constitutional requirements indicated.

*

---